VJHemOnc is committed to improving our service to you

IMW 2019 | Varying VRd regimens in real-world patients

VJHemOnc is committed to improving our service to you

Surbhi Sidana

Surbhi Sidana, MBBS Mayo Clinic, Rochester, MN, presents results on investigations into different regiments of bortezomib, lenalidomide, dexamethasone (VRd) and their efficacy and toxicity in real-world patients at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter